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Exercise training improves liver steatosis in mice
Sheril Alex1, Andreas Boss2, Arend Heerschap2 and Sander Kersten1*
Abstract
Background: Non-alcoholic fatty liver disease (NAFLD) is rapidly turning into the most common liver disorder
worldwide. One of the strategies that has been shown to effectively improve NAFLD is regular exercise, which
seems to lower steatosis partly independent of weight loss. However, limited data are available about the
mechanisms involved. The aim of the present study was to identify the mechanisms underlying the effect of
regular exercise on liver steatosis.
Methods: Non-obese male mice were rendered steatotic by feeding a sucrose-enriched choline-deficient diet. They
were then subjected to daily treadmill running for three weeks, whereas the control mice remained sedentary.
Results: Compared to the untrained mice, trained mice showed similar adipose tissue mass but had significantly
reduced size of lipid droplets in the liver coupled with a reduction in liver triglyceride content (~30 %, P < 0.05).
Levels of various plasma lipid parameters and plasma glucose were similar between the trained and untrained
mice, whereas levels of hepatic glycogen were significantly higher in the trained mice. Hepatic triglyceride secretion
rate and de novo lipogenesis were unchanged between the two sets of mice, as were indicators of lipolysis and
autophagy. Finally, whole genome expression profiling indicated a mild stimulatory effect of exercise training on
PPARα-mediated regulation of oxidative metabolism, including fatty acid oxidation.
Conclusions: Taken together, our study suggests that the lowering of hepatic steatosis by repeated exercise is
likely due to activation of fuel oxidation pathways in liver.
Background
Non-alcoholic fatty liver disease (NAFLD) is one of the
most common liver disorders worldwide. NAFLD is fre-
quently paralleled by obesity and is often referred to as
the hepatic manifestation of the metabolic syndrome [1].
The main initial feature of NAFLD is hepatic steatosis,
defined by hepatic lipid levels in excess of 5 % of liver
weight, which can further progress to steatohepatitis,
hepatic fibrosis and cirrhosis [2].
The liver is the central regulator of triglyceride and
carbohydrate metabolism. Excess storage of lipids in the
liver can be caused by a number of metabolic derange-
ments including defective fatty acid oxidation, enhanced
lipogenesis, impaired triglyceride secretion and increased
uptake of fatty acids from the circulation [3]. In humans,
hepatic steatosis is often accompanied by insulin resist-
ance. Evidence abounds that insulin resistance promotes
a fatty liver, while at the same time a fatty liver may lead
to hepatic insulin resistance, potentially causing a vicious
cycle [4]. It is generally believed that enhanced hepatic
fatty acid influx originating from either the diet or adipose
tissue lipolysis is the primary driver for development of
NAFLD during obesity and insulin resistance [5, 6], al-
though alterations in other metabolic pathways including
enhanced lipogenesis likely contribute as well.
Apart from weight loss induced by hypocaloric diets
(possibly preceded by bariatric surgery), current treat-
ment options for NAFLD are limited. With respect to
the pharmacological treatment of NAFLD, the farnesoid
X receptor agonist obetocholic acid recently showed
promise for the treatment of steatohepatitis, but its
safety profile needs further evaluation [7]. A similar case
can be made for the dual Peroxisome Proliferator Acti-
vated Receptor α/γ agonist GFT505 [8]. An alternative
remedy with a good safety record and capable of im-
proving multiple cardio-metabolic risk factors including
NAFLD is physical exercise [9]. A number of recent hu-
man trials have demonstrated a beneficial effect of regular* Correspondence: sander.kersten@wur.nl
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exercise on NAFLD [10–13]. While part of the improve-
ment in NAFLD by exercise may be related to exercise-
induced weight loss, the results of a recent meta-analysis
indicate that the benefits of regular exercise on liver fat
occur with minimal or no weight loss [14].
Efforts are underway to better understand the physio-
logical mechanisms underlying exercise-mediated im-
provement in NAFLD, primarily via the use of appropriate
animals models [15]. Nearly all studies have relied on ani-
mal models of NAFLD that are characterized by obesity.
In those studies, improvements in liver steatosis following
exercise training are often secondary to a reduction in
body weight [16–21]. Limited data are available from ani-
mal models that exhibit a reduction in liver fat by exercise
training without significant weight loss [22, 23]. Accord-
ingly, the full scope of the exercise-induced effects on
steatosis and hepatic lipid metabolism remains unclear.
The aim of the present study was to gain more insight into
the mechanisms underlying the direct effect of exercise
training on liver steatosis using a non-obese mouse model
of NAFLD. To this end, C57BL/6 mice rendered steatotic
by feeding a diet rich in sucrose but deficient in choline
(sucrose-enriched choline-deficient diet, SECDD) were
used for a treadmill-based exercise training program. Our
study results show that exercise training reduced liver fat
accumulation in the non-obese mice, possibly due to the
activation of fuel oxidation pathways in liver.
Materials and methods
Mice model of fatty liver and exercise training protocol
The non-obese mouse model of fatty liver used in this
study involved feeding male C57BL/6 mice a low-fat,
high-sucrose, choline-deficient semi-synthetic diet referred
to as sucrose-enriched choline-deficient diet (SECDD) for
five weeks. The composition of the SECDD is shown in
Table 1. Before proceeding to the main study, a pilot experi-
ment using C57BL/6 mice was conducted to examine the
effectiveness of SECDD diet in inducing liver steatosis in
comparison with feeding regular chow.
For the main study, male C57BL/6 mice were fed the
SECDD for five weeks, after which the mice were divided
into an exercise (trained) and a sedentary (untrained)
group. Mice belonging to the trained group did a treadmill-
based running exercise (TSE PhenoMaster, TSE Systems,
Germany) for a period of 3 weeks; 5 days/week, 1 h/day. In
the first week, mice ran at 14 m/min with 0° incline and in
the following weeks they ran at a speed of 16 m/min with
2° incline, representing moderate intensity exercise for the
mice. During the exercise training period, the mice contin-
ued to be fed on SECDD. The untrained group of mice
were placed on a non-moving treadmill also for a period of
3 weeks; 5 days/week, 1 h/day. Body weight and food intake
were measured weekly throughout the experiment. After
the last bout of exercise, the mice were returned to their
cage and 24 h later, a subset of mice from the trained and
untrained groups were either used to study in-vivo hepatic
triglycerides secretion (n = 7 untrained, n = 9 trained), sacri-
ficed to collect tissues for biochemical and histological
study (n = 7 untrained, n = 9 trained) or sacrificed to collect
tissues for various measurements, including hepatic de
novo lipogenesis (DNL) (n = 12 untrained, n = 12 trained).
A number of measurements were performed in all mice
within the last two cohorts, raising the number of biological
replicates to 19 or 21 per group. Prior to sacrifice, mice
were put under anesthesia using isoflurane and blood was
drawn via orbital puncture into EDTA-containing tubes.
Plasma was prepared by centrifugation at 4 °C and stored
at −80 °C. All animal experiments were approved by the
animal welfare committee of Wageningen University.
Plasma and tissue biochemical measurements
Plasma samples of non-fasted mice were analysed for
glycerol (Diasys, Germany), triglycerides (Liquicolor,
Germany), non-esterified fatty acids, NEFA (Wako
Chemicals, Germany), cholesterol (Diasys, Germany)
and alanine aminotransferase, ALT (Abcam, UK) using
commercially available kits according to manufacturer’s
instructions. Tissue glycogen levels were measured ac-
cording to a method described previously [24]. Briefly,
approximately 50 mg of tissue was digested using 1 N
NaOH at 80 °C for 15 min. Glycogen was precipitated
from the supernatant by adding 100 % ethanol at 2:1 v/v
and the precipitate was pelleted down. Pellet was washed
with 80 % ethanol and solubilised in water by incubating at
37 °C for 15 min. The glycogen sample was then
Table 1 Composition of the sucrose enriched choline deficient
diet (SECDD)
SECDD
Kcal/g 3.8
Protein (Kcal %) 18.5
Carbohydrate (Kcal %) 70.6
Fat (Kcal %) 10.8
Ingredients (g/Kg)
Casein 170
L-Cystine 3
Corn starch 125
Maltodextrin 100
Sucrose 425
Cellulose 50
Soybean oil 25
Palm oil 20
Mineral-salt mix 45
Vitamin Mix 10
Choline bitartarate 0
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digested to glucose by incubating at 42 °C for 2 h with
amyloglucosidase (Sigma, USA) in 0.2 M sodium acet-
ate buffer (pH 4.8). The amount of glucose in the
digested samples was measured using a glucose assay
kit (DiaSys, Germany).
Liver triglycerides were determined in 5 % liver homog-
enates prepared in buffer containing 250 mm sucrose,
1 mm EDTA, 10 mm Tris–HCl (pH 7.5) using a commer-
cially available kit (Liquicolor, Germany). Histological ana-
lysis of liver morphology and lipid content was done using
haematoxylin-eosin (H&E) and oil-red O (ORO) staining.
De-novo hepatic VLDL triglyceride secretion and
lipogenesis
For the VLDL triglyceride secretion test, mice fasted for
4 h were injected via the orbital plexus with 500 mg/kg
bodyweight of the lipoprotein lipase inhibitor Triton
WR1339 (Tyloxapol) as 15 % solution under general
anesthesia. Blood was collected by tail bleeding every
30 min for 2.5 h as the mice remained sedated. Plasma
triglyceride levels were measured in the blood samples
collected at different time points using an enzymatic kit
(Liquicolor, Germany). Glucose was measured in the
baseline plasma sample (Diasys, Germany).
The rate of liver de novo lipogenesis (DNL) was mea-
sured by 2H NMR using 2H enrichment of liver triglyc-
erides [25]. At the end of the last exercise training
session, a set of mice belonging to both trained and un-
trained groups were rested for 5-6 h and given an intra-
peritoneal injection of 99.9 % 2H2O (Sigma-Aldrich,
USA) as saline. The mice were then returned to their
cage and had free access to food and water. In order to
have constant body water enrichment, the drinking
water was enriched with 2H2O at 3 %. They were then
sacrificed after 16 h, and blood samples were obtained
for the determination of plasma 2H-enrichment. The
livers were excised and hepatic lipids extracted [26]. The
extract was dissolved in chloroform and a mixture of 1H/
2H-pyrazine was added as reference. Proton-decoupled 2H
NMR spectra (WALTZ 16-decoupling, 90° hard pulse for
excitation) and 1H-spectra of lipids were acquired (Bruker
Avance III 500 MHz) and the methyl-group signals of the
1H-and 2H-spectra were quantified relative to the signal of
the respective standard. The 2H-enrichment of body-
water was determined as previously described [27]. The
ratio between the 2H-enrichment of the methyl-groups of
hepatic triglycerides and body-water represents the frac-
tional contribution of DNL to hepatic triglycerides.
Hepatic gene and protein expression levels
Total RNA was isolated from the mouse tissues using
TRIzol reagent (Invitrogen, Breda, The Netherlands).
RNA was reverse transcribed using RevertAid First strand
cDNA synthesis kit (Thermoscientific). Real-time
PCR was carried out using SensiMiX (Bioline) on a
CFX 384 Bio-Rad thermal cycler (Bio-Rad). 36B4 was used
as housekeeping gene. Primers sequences used are shown
in Table 2.
Tissue homogenates were made using RIPA buffer
with added protease inhibitor cocktail and spun to pellet
the cell debris. Supernatant was collected and the pro-
tein concentration determined using the BCA method
(Pierce BCA protein assay kit). Equal amount of protein
was subjected to a 4-15 % gradient gel electrophoresis
and immunoblotted using the following antibodies for
Tubulin (1:1000, SantaCruz), GAPDH (1:1000, Santa
Cruz), LC3 and p62 (1:1000, Novus biologicals); AMPK,
pAMPK, Cytochrome C (1:1000, Cell signalling technol-
ogy). Blots were further incubated with the appropriate
HRP conjugated secondary antibody (1:5000) and devel-
oped using BioRad Clarity (BioRad, USA). The bands
were visualised using ChemiDoc system (BioRad, USA)
and quantified with Image Lab software.
Micro-array analysis
After TRIzol, RNA was further purified using RNeasy
micro columns (Qiagen, Venlo, the Netherlands). RNA
integrity was checked on an Agilent 2100 bioanalyzer
(Agilent Technologies, Amsterdam, the Netherlands)
using 6000 Nano Chips according to the manufacturer’s
instructions. Purified RNA (100 ng) was labeled with
the Ambion WT expression kit (Invitrogen) and hy-
bridized to an Affymetrix Mouse Gene 1.1 ST array
plate (Affymetrix, Santa Clara, CA). Hybridization, wash-
ing, and scanning were carried out on an Affymetrix
GeneTitan platform according to the instruction by the
manufacturer. Arrays were normalized using the Robust
Multiarray Average method [28, 29]. Probe sets were de-
fined according to Dai et al. [30]. In this method probes
are assigned to Entrez IDs as an unique gene identifier.
The P values were calculated using an Intensity-Based
Moderated T-statistic (IBMT) [31]. The microarray data
were submitted to the Gene Expression Omnibus (acces-
sion number pending). Gene set enrichment analysis
(GSEA) was used to find enriched gene sets in the induced
or suppressed genes [32]. Genes were ranked based on the
IBMT-statistic and subsequently analyzed for over- or un-
derrepresentation in predefined gene sets derived from
Gene Ontology, KEGG, National Cancer Institute, PFAM,
Biocarta, Reactome and WikiPathways pathway databases.
Only gene sets consisting of more than 15 and fewer than
500 genes were taken into account. Statistical significance
of GSEA results was determined using 1000 permutations.
Statistical analysis
All the results are expressed as mean ± SEM. Compari-
sons were made between the trained and untrained
mice. Statistical significance was tested using a two-
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tailed Student’s t-test and p < 0.05 was considered as sig-
nificantly different.
Results
Exercise training reduced liver fat in SECDD-fed steatotic
mice
We employed a non-obese steatosis model, 1) to avoid
the possible interference of obesity on the ability of the
mice to run, 2) to lower the chance of confounding by
exercise-induced weight loss. The non-obese steatosis
model consisted of five weeks of feeding C57BL/6 mice
a diet enriched in sucrose but deficient in choline (su-
crose-enriched choline-deficient diet, SECDD). Hema-
toxilin & eosin staining (Fig. 1a) and oil red O staining
(Fig. 1b) indicated increased number and size of lipid
droplets in livers of mice fed the SECDD. Biochemical
analysis showed nearly six-fold higher liver triglyceride
levels in the SECDD-fed mice as compared with mice
fed chow (Fig. 1c). Gene expression analysis by qPCR
showed significant upregulation of a limited number of
genes involved in hepatic lipogenesis, including stearoyl-
CoA desaturase (Scd1), fatty acid synthase (Fasn) and
Glycerol 3-phosphate acyltransferase (Gpam) in the mice
fed SECDD (Fig. 1d). Expression of the inflammatory
marker Interleukin-1β (Il1b) was also increased. Consist-
ent with the steatotic phenotype, plasma ALT levels
were increased three-fold in mice fed SECDD (Fig. 1e).
Taken together, SECDD feeding serves as an appropriate
model to induce hepatic steatosis without high-fat
overfeeding.
To study the effect of endurance exercise training on
liver fat content, mice rendered steatotic by SECDD
feeding were subjected to a three week exercise regimen
consisting of one hour of treadmill running daily. Seden-
tary (untrained) mice were placed on a non-moving
treadmill lane for one hour daily. Twenty-four hours
after the last exercise bout, the mice were subjected to
different types of measurements or sacrificed. Final
bodyweight and bodyweight gain were not different be-
tween the trained and untrained mice (Fig. 2a). Also,
liver weight, weight of the epididymal fat pad, brown
adipose tissue weight, and weights of vastus and gastro-
cnemius muscle were not different between the trained
and untrained mice (Fig. 2b). As expected, exercise train-
ing was associated with a noticeable increase in cyto-
chrome C content in gastrocnemius muscle (Fig. 2c).
Strikingly, staining of liver sections by hematoxilin &
eosin (Fig. 2d) and oil red O staining (Fig. 2e) showed
fewer and smaller lipid vacuoles in the liver of the
trained mice as compared with the untrained mice. The
reduced lipid accumulation in the livers of the trained
mice was supported by oil red O staining and biochemical
analysis, which showed an approximate 30 % reduction in
liver triglyceride content (P < 0.05; Fig. 2f). Despite the
Table 2 List of primers
Gene Forward primer Reverse primer
Scd1 TAGCCTGTAAAAGATTTCTGCAAACC CCGGAGACCCTTAGATCGA
Fasn TCCTGGGAGGAATGTAAACAGC CACAAATTCATTCACTGCAGCC
Gpam ACAGTTGGCACAATAGACGTTT CCTTCCATTTCAGTGTTGCAGA
CD36 TCCAGCCAATGCCTTTGC TGGAGATTACTTTTCAGTGCAGAA
Fabp2 AAAGGAAACCTCATTGCCACCA AATGTCGCCCAATGTCATGGTA
Mttp ATACAAGCTCACGTACTCCACT TCCACAGTAACACAACGTCCA
Nr1h3 GCT CTG CTC ATT GCC ATC AG TGTTGCAGCCTCTCTACTTGGA
Acaca1 GCCATTGGTATTGGGGCTTACC CCCGACCAAGGACTTTGTTG
Srebf1 GGAGCCATGGATTGCACATT CCTGTCTCACCCCCAGCATA
Mlxipl CTGGGGACCTAAACAGGAGC GAAGCCACCCTATAGCTCCC
Slc2a2 TCAGAAGACAAGATCACCGGA GCTGGTGTGACTGTAAGTGGG
Lipe TCAACCGACCAGCAGTGCTC CTCTGGGTCTATGGCGAATC
Pnpla2 CAACGCCACTCACATCTACGG GGACACCTCAATAATGTTGGCAC
Lipa TGTTCGTTTTCACCATTGGGA CGCATGATTATCTCGGTCACA
Atg3 ACACGGTGAAGGGAAAGGC TGGTGGACTAAGTGATCTCCAG
Atg5 AGCCAGGTGATGATTCACGG GGCTGGGGGACAATGCTAA
Sqstm1 AGGATGGGGACTTGGTTGC TCACAGATCACATTGGGGTGC
Map1lc3b TTATAGAGCGATACAAGGGGGAG CGCCGTCTGATTATCTTGATGAG
Il-1b CAGGCAGGCAGTATCACTCA AGGTGCTCATGTCCTCATCC
36b4 ATGGGTACAAGCGCGTCCTG GCCTTGACCTTTTCAGTAAG
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reduced hepatic steaotosis following training, plasma
ALT levels (Fig. 3a) and hepatic expression of inflam-
matory marker ll-1β (Fig. 3b) were not affected by ex-
ercise training. Furthermore, exercise training did not
affect plasma triglyceride, free fatty acids, glycerol or
cholesterol levels (Fig. 3c). Plasma glucose and insulin
levels also remained unchanged (Fig. 3d and e). Inter-
estingly, liver glycogen levels were significantly higher
in the trained mice as compared with the untrained
mice (Fig. 3f ), whereas the opposite pattern was ob-
served for muscle glycogen levels (Fig. 3g).
The reduction in liver triglycerides in the trained
mice may be explained by a number of mechanisms
including enhanced hepatic triglyceride secretion, de-
creased hepatic lipogenesis, enhanced intracellular
lipolysis, and increased hepatic fatty acid oxidation.
To differentiate between these possibilities, we first
determined the effect of exercise training on hepatic
triglyceride secretion via injections with tyloxapol. No
significant difference in the rate of increase in plasma
triglyceride levels following tyloxapol injection was
observed between trained and untrained mice (Fig. 4a),
indicating that hepatic triglyceride secretion was un-
affected by exercise training. Next we studied the contribu-
tion of de novo lipogenesis towards the liver triglyceride
pool using deuterium-labeled water. It was observed that in
the untrained mice about 9 % of hepatic triglycerides were
derived from hepatic de novo lipogenesis. The same num-
ber was found in trained mice, suggesting that exercise
training did not alter the rate of de novo lipogenesis
(Fig. 4b). qPCR analysis also did not reveal changes in ex-
pression of relevant lipogenic genes (Fig. 4c).
To investigate whether exercise training may affect
intracellular lipolysis, we measured expression of genes
involved in lipolytic pathways, including Lipe (hormone
sensitive lipase), Pnpla2 (adipose triglyceride lipase), and
Lipa (lysosomal lipase), as well as the markers of autoph-
agy such as microtubule-associated protein 1 light chain
3 beta Map1lc3b (LC3b), sequestosome 1 (Sqstm1/p62),
autophagy-related 3 (Atg3) and Atg5 (Fig. 5a). None of
these genes was differentially expressed between trained
and untrained mice, with the exception of Map1lc3b
(LC3b), which was slightly but significantly higher in the
trained mice. Levels of Sqstm1 protein and the relative
abundance of LC3I and LC3II, which is used as marker
for activated autophagy, were similar between the two
groups (Fig. 5b and c).
To further investigate the effect of exercise training in
mouse liver, we performed microarray analysis. To deter-
mine which pathways were affected by exercise training
we performed gene set enrichment analysis. The analysis
revealed significant induction of a number of pathways,
as shown in Fig. 6a. Interestingly, genes within the gene
set “fatty acid beta oxidation” and “PPARα targets” were
significantly enriched in the livers of trained mice as
compared to the untrained mice. Although PPARα expres-
sion itself was not upregulated, multiple genes that are
under its transcriptional control were modestly induced in
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the trained mice (Fig. 6b). These data are suggestive of
relatively weak induction of PPARα-dependent genes and
pathways, including fatty acid oxidation. To test whether
mitochondrial metabolism in liver is activated by exercise
training, we measured activation of AMP-activated protein
kinase (AMPK). We reasoned that if mitochondrial me-
tabolism is elevated in the trained animals, ATP levels
may be higher in the resting state leading to lower activa-
tion of AMPK. Consistent with this notion, it was found
that pAMPK was markedly lower in trained mice as com-
pared to the untrained mice (Fig. 6c).
An additional explanation for the reduction in liver tri-
glycerides by exercise training might be that every single
exercise bout causes a minor decrease in the liver trigly-
ceride pool, cumulatively leading to the 30 % reduction
in hepatic triglyceride levels after 3 weeks of exercise
training. Such a minimal reduction in liver triglyceride
levels by a single exercise bout would be impossible to
demonstrate experimentally, but may be indirectly de-
duced from induction or repression of certain metabolic
pathways. Indeed, a single 90 min exercise bout in mice
significantly reduced hepatic expression of the lipogenic
transcription factor Sterol regulatory element binding
protein 1 (Srebf1) and its target Gpam (Fig. 6d).
Discussion
In the current study, we investigated the effect of exer-
cise training on liver triglyceride levels using a non-
obese mouse model of steatosis. It was observed that a
treadmill based exercise training for three weeks reduced
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liver fat accumulation without causing any changes in
adipose tissue mass. Theoretically, a reduction in liver
triglyceride levels can be caused by a number of different
mechanisms, including decreased hepatic lipogenesis
and increased triglyceride secretion. In our study, exer-
cise training did not affect de novo lipogenesis, nor did it
affect hepatic triglyceride secretion. Most of the fatty
acids that serve as substrates for hepatic triglycerides are
derived from circulating free fatty acids. In our study we
did not observe any sustained changes in plasma free
fatty acid levels. Unfortunately, we were unable to dir-
ectly determine free fatty acid uptake and fluxes into the
liver. Further, we did not find strong indications that
lipophagy, describing the breakdown of intracellular
lipids via autophagy [33], was altered in the trained mice.
Instead, our data suggest that exercise training is associ-
ated with mild activation of PPARα-mediated regulation
of oxidative metabolism in liver at rest, which may ac-
count for the observed reduction in liver triglycerides. It
should be noted that the magnitude of upregulation of
genes involved in beta oxidation as well as other PPARα
targets was rather small and could only be made visible
by performing whole genome expression profiling. Our
results are in agreement with previous studies that have
found a reduction in liver triglycerides following exercise
training. As an explanation, these studies have hinted at
reduced fatty acid uptake [17], increased mitochondrial
oxidation and PPARα expression [18, 20] and reduced
lipogenesis [18–20].
As an alternative explanation, we cannot exclude that
every single exercise bout caused a very small decrease
in the liver triglyceride pool, cumulatively causing the
30 % decrease in liver fat after 3 weeks of exercise train-
ing. Although such a minimal change in liver fat by a
single exercise bout cannot be measured, it may be in-
directly reflected in induction or suppression of certain
metabolic pathways. We found that a single exercise bout
significantly reduced expression of the lipogenic genes
Srebf1 and Gpam. In line with this result, a single aerobic
exercise bout performed after a carbohydrate-rich meal
was found to significantly reduce hepatic triglyceride syn-
thesis and de novo lipogenesis in human subjects [34].
Whereas liver triglycerides were reduced following
3 weeks of exercise training, liver glycogen content
was significantly increased by exercise training. Liver
and skeletal muscle are two major repositories that
stores glucose in the form of glycogen. Liver glycogen
levels are correlated with oxidative capacity of muscle,
and are therefore an important determinant of exer-
cise capacity in rodents [35]. While liver glycogen
levels are comparable in human and mice, muscle glyco-
gen levels are ~10 fold lower in mice compared to human
[36]. Accordingly, the increase in liver glycogen may rep-
resent an adaptive response to regular exercise similar to
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and p62. c Quantification of immunoblots. Error bars represent standard error (n = 4–12). Asterisk indicates statistically significant according to
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the glycogen supercompensation observed in human
muscle. The observed increase in liver glycogen levels
may be explained by the reduction in AMPK phosphoryl-
ation, one of the key regulators of glycogen synthase 2.
AMPK has been shown to be able to phosphorylate glyco-
gen synthase 2 and thereby reduce its affinity towards its
substrates UDP-Glucose and Glucose-6-P [37]. Induction
of glycogen synthase 2 may be further mediated by
Gys2
Txnip
Hsd17b12
Oat
Hibch
Odc1
Acot4
Akr1b10
Npc1
Cpt1b
Aqp9
Hsd17b4
Ces1g
Lipg
Fads1
Ces1d
Rab9
Lipe
Gls
Acadl
Cyp7a1
Acadm
Fabp4
Decr1
Pex11a
Gsta3
Lrp4
Nr1h4
Acsl1
Ucp3
Slc10a2
Cth
Mogat1
Ucp2
Cav1
Aldh3a2
Abcd2
Cidea
Aldh9a1
Cyp4a12a
Scd2
Acsl3
Fads2
Cpt1a
Gyk
Lpin2
Fbp2
Acot3
Pnpla2
Pctp
Acot12
Aqp7
Acad10
Decr2
Acox1
Acot2
Cidec
Pltp
Fabp1
A
0 1 2 3
KEGG_ARGININE & PROLINE METABOLISM
KEGG_DRUG METABOLISM - CYTOCHROME P450
PPARA_TARGETS
KEGG_STARCH & SUCROSE METABOLISM
NCI_EPHA_FWDPATHWAY
WIP_MM_FATTY_ACID_BETA_OXIDATION
REACT_G-PROTEIN MEDIATED EVENTS
WIP_MM_G1_TO_S_CELL_CYCLE_CONTROL
BIOC_CELLCYCLEPATHWAY
REACT_CHOLESTEROL BIOSYNTHESIS
WIP_MM_STRIATED_MUSCLE_CONTRACTION
NCI_P38ALPHABETAPATHWAY
KEGG_ASCORBATE & ALDARATE METABOLISM
BIOC_GATA3PATHWAY
REACT_INSULIN RECEPTOR RECYCLING
KEGG_STEROID BIOSYNTHESIS
Normalized enrichment score
untrained            trained
p-AMPK
AMPK
Untrained Trained
TUBULIN
B
C
0
0.2
0.4
0.6
0.8
1
1.2
1.4 Sedentary
Exercise
Fo
ld
 c
ha
ng
e
D
*
*
Fig. 6 Exercise training altered liver oxidative processes. a Gene sets positively enriched in the livers of trained mice as compared to untrained
mice ranked according to normalized enrichment score (gene set enrichment analysis). The enrichment score reflects the degree to which a
gene set is overrepresented at the top or bottom of a ranked list of genes. Normalization accounts for differences in gene set size and in
correlations between gene sets and the expression dataset. The normalized enrichment score is most often used to compare analysis results
across gene sets. b Gene expression changes in liver illustrated by heat map of positively enriched genes belonging to the gene set PPAR
targets. c Immunoblot of AMPK and phospho-AMPK. d Expression of selected genes in liver of mice after 90 min on a non-moving treadmill or
a running treadmill (12 m/min) [42], as determined by qPCR. Asterisk indicates statistically significant according to Student’s t-test (P < 0.05)
Alex et al. Nutrition & Metabolism  (2015) 12:29 Page 9 of 11
increased gene expression. In contrast to liver glycogen,
muscle glycogen content was reduced in the trained mice.
The reason is unclear but may be due to an adaptive shift
in fuel utilisation from glycogen to increased use of lipid
fuels. Alternatively, it may be a carryover effect from the
last exercise bout.
The transition from an exercise phase to a post-exercise
phase is associated with a number of metabolic changes in
the liver that may be influenced by AMPK. Activation of
AMPK during exercise protects the cell against ATP de-
pletion by stimulating processes such as fatty acid oxida-
tion and suppressing ATP-utilizing lipogenic pathways.
Accordingly, the observed decrease in hepatic AMPK ac-
tivity in the trained mice may represent a transient physio-
logical change to favour anabolic processes during the
post-exercise phase. Along these lines, a time-dependent
reduction in liver AMPK activity lasting up to 24 h has
been reported during a similar physiological situation of
fasting and refeeding [38].
Regular exercise is known to lower circulating trigly-
ceride levels [39], likely due to improved triglyceride
clearance mediated by elevated lipoprotein lipase activity
in muscle [40]. The triglyceride-lowering effect is con-
sidered as an acute response to recent exercise rather
than a long term training adaptation [41]. Previously, we
found that a single 90 min treadmill exercise bout sig-
nificantly reduced plasma triglyceride levels in mice,
which was opposed by the lipoprotein lipase inhibitor
ANGPTL4 [42]. The acute effect of exercise on plasma
triglycerides rapidly reverses with detraining, which may
explain the lack of difference in plasma triglycerides be-
tween trained and untrained mice. Alternatively, the lack
of difference in triglycerides may be because the mice
were not fasted at the time of sacrifice.
Several different animal models for hepatic steatosis
are routinely used in NAFLD research. These models
each have their specific advantages and disadvantages,
and vary in their mechanistic and phenotypical resem-
blance to human NAFLD [15]. The animal model used
in our study was specifically chosen to avoid the poten-
tial confounding of obesity and exercise-induced fat loss.
By feeding a diet rich in sucrose but deficient in choline
mice develop mild steatosis as shown by increased liver
fat accumulation and liver enzymes. The likely mechan-
ism is a combination of the lipogenic effect of dietary su-
crose coupled to the influence of choline deficiency on
lipoprotein metabolism and oxidative stress [43].
The use of non-obese mice could also be considered a
limitation since NAFLD in humans is often, though not
exclusively, accompanied by obesity. Previous studies in
different mouse models of NAFLD including diet-induced
obese mice confirm the suppressive effect of exercise
training on liver triglycerides and also point to reduction
of hepatic inflammation and fibrosis [16–23]. It should be
noted, however, that the reduction in liver triglycerides in
some studies may be at least partly caused by reduced
adiposity following exercise training [16–21], which
makes it difficult to make an appropriate comparison
with our study. In our study, exercise training neither
influenced bodyweight nor adipose tissue weight.
Conclusions
The results of our study indicate that treadmill-based
exercise training for three weeks reduced liver fat accu-
mulation in mice without causing any changes in adi-
pose tissue mass. Exploration of the potential underlying
mechanism did not reveal a significant effect of exercise
training on liver triglyceride secretion, de novo lipogen-
esis, or lipolysis/autophagy. Instead, our data point to a
weak stimulatory effect of exercise training on PPARα-
mediated regulation of oxidative metabolism. Taken to-
gether, our study suggests that the lowering of hepatic
steatosis by repeated exercise is probably due to activa-
tion of fuel oxidation pathways in liver.
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